Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Roche touts new flu drug as Tamiflu suffers generics hit

      Roche touts new flu drug as Tamiflu suffers generics hit

      Ruby Khatun Khatun19 July 2018 9:30 AM IST
      ZURICH: Swiss drugmaker Roche’s hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed...
      Valsartan issues: China heart drug sold globally may have had impurity since 2012

      Valsartan issues: China heart drug sold globally may have had impurity since 2012

      Ruby Khatun Khatun18 July 2018 4:05 PM IST
      LONDON: A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to...
      Rs 47 Crore Penalty on Glenmark- Pharma Co to appeal before Company Law Tribunal

      Rs 47 Crore Penalty on Glenmark- Pharma Co to appeal before Company Law Tribunal

      Ruby Khatun Khatun18 July 2018 3:50 PM IST
      As per the CCI order Glenmark, Divine, Hetero and B M Thakkar have to pay a total penalty of Rs 46.43 crore. Also, three officials of Glenmark and one...
      Zydus Cadila gets USFDA approval for acne treatment

      Zydus Cadila gets USFDA approval for acne treatment

      Ruby Khatun Khatun18 July 2018 3:44 PM IST
      New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Clindamycin Phosphate Topical Solution,...
      Glenmark gets USFDA approval for cholesterol drug

      Glenmark gets USFDA approval for cholesterol drug

      Ruby Khatun Khatun18 July 2018 3:30 PM IST
      New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Colesevelam Hydrochloride for oral suspension, used...
      FDA to more aggressively tackle disruptive drug shortages

      FDA to more aggressively tackle disruptive drug shortages

      Ruby Khatun Khatun18 July 2018 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) said Thursday it wants to more aggressively fight medication shortages that have led to rationing of some...
      Johnson and Johnsons quarterly profit rises 3.3 percent

      Johnson and Johnson's quarterly profit rises 3.3 percent

      Ruby Khatun Khatun18 July 2018 9:31 AM IST
      Johnson and Johnson reported a 3.3 percent rise in quarterly profit, as higher sales of cancer drugs Zytiga and Darzalex helped offset pressure on its...
      NFL, American Cancer Society award 3.2 million dollar in grants

      NFL, American Cancer Society award 3.2 million dollar in grants

      Ruby Khatun Khatun18 July 2018 9:30 AM IST
      NEW YORK: The NFL has partnered with the American Cancer Society and awarded $3.2 million in grant funding to address disparities in breast cancer...
      Marketing unapproved FDC drugs: Ajanta Pharma under scanner

      Marketing unapproved FDC drugs: Ajanta Pharma under scanner

      Ruby Khatun Khatun17 July 2018 5:41 PM IST
      Mumbai: Controversy is coming the way of Ajanta Pharma as the firm has come under the CDSCO scanner for allegedly selling unapproved FDCs.It is...
      Lupin gets UK MHRA approval for Goa facility

      Lupin gets UK MHRA approval for Goa facility

      Ruby Khatun Khatun17 July 2018 10:30 AM IST
      New Delhi: Pharma major Lupin announced that it has received approval from the UK health regulator for its Goa facility.Lupin in a regulatory filing...
      First drug for smallpox approved

      First drug for smallpox approved

      Ruby Khatun Khatun17 July 2018 10:15 AM IST
      The U.S. Food and Drug Administration (FDA) approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the...
      Suven Life gets patents from Europe, South Korea

      Suven Life gets patents from Europe, South Korea

      Ruby Khatun Khatun17 July 2018 10:00 AM IST
      New Delhi: Suven Life Sciences said it has been granted a product patent by Europe and South Korea each for a new chemical entity (NCE) used in the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok